The global stem cell assay market is anticipated to generate revenue of $3188.4 million by 2027 and grow at a CAGR of 18.05% between 2019 and 2027. Rising investment in the research activities is the key factor augmenting the growth of the stem cell assay market. The following factors primarily drive the stem cell assay market:

GLOBAL STEM CELL ASSAY MARKET FORECAST 2019-2027

Global Stem Cell Assay Market By Type Of Assay (cell Viability & Toxicity Assays, Isolation/purification Assays, Cell Identification Assays, Cell Differentiation Assays, Cell Function Assays, Cell Apoptosis Assays) By Product (instruments, Detection Kit) By Kits (adult Stem Cell Kit, Human Embryonic Stem Cell Kit) By Application (regenerative Medicines & Therapy Development Market, Drug Discovery & Development Market, Clinical Research) By End-user (research Institutes, Industry Research) Y Geography.

Request free sample

Report Summary

The global stem cell assay market is anticipated to generate revenue of $3188.4 million by 2027 and grow at a CAGR of 18.05% between 2019 and 2027. Rising investment in the research activities is the key factor augmenting the growth of the stem cell assay market. The following factors primarily drive the stem cell assay market:

  • Rising adoption of stem cell assay
  • Technological advancement
  • Growing spending in stem cell research
  • Potential of stem cells in regenerative medicine

Stem Cell Assay Market

To know more about this report, request a free sample copy.

The important drivers that are increasing the growth of the global stem cell assay market are the rising adoption of stem cell assay and technological advancement. The rising acceptance of stem cell assay for drug testing and screening is one of the major reasons driving the industry research market. Technological advancement involving stem cells therapy provides fundamental tools and techniques for R&D and application of hESC therapy.

The applications and types of the assay of stem cell assay market are used extensively for various purposes. The regenerative medicines & therapy development market is expected to dominate the global stem cell assay market. Regenerative medicine helps the natural remedial processes which work more effectively and more quickly.

Regenerative medicines & therapy development market is sub-segmented into the orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, and oncology. Stem cell therapy has opened a new avenue in the area of drug discovery and development. A clinical research study also covered the supportive care for the treatment of veno-occlusive disease treatment. Viability assay is a common procedure to determine the viability of cells present in the suspension. Cell separation techniques use genetic expressions and surface protein for isolating a specific stem cell. Stem cell identification assay simplifies the complex process of identification as the stem cells are highly indistinguishable from their progeny. The stem cell assay market by cell differentiation assays has been driven by huge investments that have been deployed for conducting blood cancer-based research. Apoptosis assay is utilized in cancer-based stem cell research, heart stroke and the Alzheimer disease.

Ethical concern related to stem cell research and high cost for treatment are the major factors hindering the stem cell assay market. Stem cell and other advanced biologic treatments are among the key costly therapies in the medical armory. Ethical issues existing in human embryonic stem cell research and its clinical applications are primarily focused around the fact that the embryo is considered to be a whole person.

The global stem cell assay market segments include types of assay, product, kits, applications, and end-user.

Types of Assay are segmented into:

  • Cell viability & toxicity assays
  • Cell apoptosis assays
  • Cell function assays
  • Cell identification assays
  • Isolation/purification assays
  • Cell differentiation assays

Product is segmented into:

  • Instruments
  • Detection kit

Kits are segmented into:

  • Adult stem cell kit
    • Mesenchymal stem cell kit
    • Induced pluripotent stem cell kit
    • Hematopoietic stem cell kit
    • Neuronal stem cell kit
    • Umbilical cord stem cell kit
  • Human embryonic stem cell kit
    • Regenerative medicine
    • Stem cell biology research
    • Tissue engineering
    • Toxicology testing

Applications are segmented into:

  • Regenerative medicines & therapy development market
    • Orthopedic & musculoskeletal spine
    • Oncology
    • Cardiovascular
    • Dermatology
    • Central nervous system
  • Clinical research
  • Drug discovery & development market

End-User is segmented into:

  • Research institutes
  • Industry research

This report covered the present market conditions and the growth prospects of the global stem cell assay market for 2019-2027 forecasting tenure and considered the revenue generated through the sales of stem cell assay for types of assay, product, kits, applications, and end-user to calculate the market size by considering 2018 as the base year.

Geographically, the global stem cell assay market has been segmented into four major regions, which include:

The stem cell assay market in North America is expected to hold the largest share by 2027. The rising occurrence of chronic ailments mostly determines the development in the North America market and growing research and development spending in the biotechnology sector.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the stem cell assay market. The growing prevalence of chronic diseases such as cancer, cardiovascular disorders, etc. that have become the crucial development driver of the Asia Pacific market. The rising occurrence of chronic disorders and an upsurge in the patient lot in India coupled with the growing biotechnology industry in the country is increasing the growth of the India stem cell assay market.

The stem cell assay market is segmented by products which are sub-divided into detection kit and instruments, also segmented by kits which are sub-divided into human embryonic stem cell kit and adult stem cell kit, and segmented by end-user which is sub-divided into Industrial Research and Research Institutes.

Based on various instruments the market is further diversified into a flow cytometer, cell imaging systems, microelectrode arrays, and automated cell counter. The stem cells assay market by adult stem cells kits is segmented into mesenchyme stem cells kits, induced pluripotent stem cells kits, hematopoietic stem cells kits, neuronal stem cells, and umbilical cord blood cells. Human embryonic stems cells can also be used as a tool for creating regenerative medicine and its research. Increasing stem cell research for the treatment of Parkinson’s disease and cancer is also driving the market of stem cell assay in research institutes. Industry-sponsored cell therapy trials have also boosted the demand for stem cells assay for industrial research.

The major market players of the global stem cell assay market are:

  • GE Healthcare
  • Becton Dickinson
  • Corning Inc.
  • Fibrocell Science Inc.
  • Thermo fisher scientific Pvt. Ltd.

Company profiles cover the analysis of important players. GE Healthcare offers information technologies, medical imaging and medical diagnostics, drug discovery, patient monitoring systems, performance solutions services, and biopharmaceutical manufacturing technologies. Thermo Fisher Scientific Pvt. Ltd. develops and delivers its products to research institutions and government agencies, universities, hospitals, and clinical diagnostic labs, pharmaceutical, and biotech companies.

Key findings of the global stem cell assay market:

  • Industry research is the leading end-user segment
  • Increasing demand for regenerative medicine
  • Cell viability & toxicity assays are majorly used
  • Adult stem cell kits are the fastest growing stem cell kit

Table of Contents

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • INDUSTRY RESEARCH IS THE LEADING END-USER SEGMENT
      • INCREASING DEMAND FOR REGENERATIVE MEDICINE
      • CELL VIABILITY & TOXICITY ASSAYS ARE MAJORLY USED
      • ADULT STEM CELL KITS ARE THE FASTEST GROWING STEM CELL KIT
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • RISING ADOPTION OF STEM CELL ASSAY
      • TECHNOLOGICAL ADVANCEMENT
      • GROWING SPENDING IN STEM CELL RESEARCH
      • POTENTIAL OF STEM CELLS IN REGENERATIVE MEDICINE
    • MARKET RESTRAINTS
      • HIGH COST FOR TREATMENT
      • SLOW RESPONSE TIME OF REGULATORY BODIES
      • ETHICAL CONCERN RELATED TO STEM CELL RESEARCH
    • MARKET OPPORTUNITIES
      • CHANGING MARKET DYNAMICS
      • EMERGING APPLICATION AS A DRUG DISCOVERY TOOL
    • MARKET CHALLENGES
      • ISSUE RELATED TO THE PATIENT’S IMMUNE SYSTEM
      • STRINGENT GOVERNMENT REGULATIONS
  1. MARKET BY TYPE OF ASSAY
    • CELL VIABILITY & TOXICITY ASSAYS
    • ISOLATION/PURIFICATION ASSAYS
    • CELL IDENTIFICATION ASSAYS
    • CELL DIFFERENTIATION ASSAYS
    • CELL FUNCTION ASSAYS
    • CELL APOPTOSIS ASSAYS
  2. MARKET BY PRODUCT
    • INSTRUMENTS
    • DETECTION KIT
  3. MARKET BY KITS
    • ADULT STEM CELL KIT
      • MESENCHYMAL STEM CELL KIT
      • INDUCED PLURIPOTENT STEM CELL KIT
      • HEMATOPOIETIC STEM CELL KIT
      • NEURONAL STEM CELL KIT
      • UMBILICAL CORD STEM CELL KIT
    • HUMAN EMBRYONIC STEM CELL KIT
      • REGENERATIVE MEDICINE
      • STEM CELL BIOLOGY RESEARCH
      • TISSUE ENGINEERING
      • TOXICOLOGY TESTING
  1. MARKET BY APPLICATION
    • REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET
      • ORTHOPEDIC & MUSCULOSKELETAL SPINE
      • DERMATOLOGY
      • CARDIOVASCULAR
      • CENTRAL NERVOUS SYSTEM
      • ONCOLOGY
    • DRUG DISCOVERY & DEVELOPMENT MARKET
    • CLINICAL RESEARCH
  2. MARKET BY END-USER
    • RESEARCH INSTITUTES
    • INDUSTRY RESEARCH
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • KEY BUYING CRITERIA
      • PRICING
      • EFFICACY
      • ACCURACY
    • VALUE CHAIN ANALYSIS
    • PEST ANALYSIS
    • PATENT ANALYSIS
      • NORTH AMERICA PATENT ANALYSIS
      • EUROPE PATENT ANALYSIS
      • ASIA PACIFIC PATENT ANALYSIS
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA-PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
  • COMPANY PROFILES
    • BECTON DICKINSON
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • BIO-RAD
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • CELL BIO LABS, INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • CORNING INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • FIBROCELL SCIENCE INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • GE HEALTHCARE
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • HEMOGENIX
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • MERCK MILLIPORE (HOLDING COMPANY IS MERCK KGAA)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • PROMEGA CORPORATION
      • COMPANY OVERVIEW
      • PRODUCTS PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • R&D SYSTEMS
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • STEM CELL TECHNOLOGIES
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • STRYKER CORPORATION
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • TAKARA HOLDINGS INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • THERMO FISHER
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES

 

TABLE LIST

TABLE  1       GLOBAL STEM CELL ASSAY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  2       GLOBAL STEM CELL ASSAY MARKET BY TYPE OF ASSAY 2019-2027 ($ MILLION)

TABLE  3       GLOBAL CELL VIABILITY & TOXICITY ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  4       GLOBAL ISOLATION/PURIFICATION ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  5       GLOBAL CELL IDENTIFICATION ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  6       GLOBAL CELL DIFFERENTIATION ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  7       GLOBAL CELL FUNCTION ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  8       GLOBAL CELL APOPTOSIS ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  9       GLOBAL STEM CELL ASSAY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE  10     GLOBAL INSTRUMENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  11     GLOBAL DETECTION KIT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  12     GLOBAL STEM CELL ASSAY MARKET BY KITS 2019-2027 ($ MILLION)

TABLE  13     GLOBAL ADULT STEM CELL KIT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  14     GLOBAL ADULT STEM CELL KIT MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE  15     GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  16     GLOBAL STEM CELL ASSAY MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE  17     GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  18     GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE  19     GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  20     GLOBAL CLINICAL RESEARCH BY REGION 2019-2027 ($ MILLION)

TABLE  21     GLOBAL STEM CELL ASSAY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE  22     GLOBAL RESEARCH INSTITUTES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  23     RESEARCH ACTIVITIES ON DIFFERENT TYPE OF STEM CELLS

TABLE  24     GLOBAL INDUSTRY RESEARCH MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  25     GLOBAL STEM CELL ASSAY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  26     NORTH AMERICA STEM CELL ASSAY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE  27     EUROPE STEM CELL ASSAY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE  28     ASIA-PACIFIC STEM CELL ASSAY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE  29     STEM CELL RESEARCH POLICIES IN SOME ASIAN COUNTRIES

TABLE  30     REST OF WORLD STEM CELL ASSAY MARKET BY COUNTRY 2019-2027 ($ MILLION)

 

FIGURES LIST

FIGURE  1     GLOBAL STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  2     GLOBAL STEM CELL ASSAY MARKET SHARE BY TYPE OF ASSAY 2018 & 2027 (%)

FIGURE  3     GLOBAL STEM CELL ASSAY MARKET BY CELL VIABILITY & TOXICITY ASSAYS 2019-2027 ($ MILLION)

FIGURE  4     GLOBAL STEM CELL ASSAY MARKET BY ISOLATION/PURIFICATION ASSAYS 2019-2027 ($ MILLION)

FIGURE  5     GLOBAL STEM CELL ASSAY MARKET BY CELL IDENTIFICATION ASSAYS 2019-2027 ($ MILLION)

FIGURE  6     GLOBAL STEM CELL ASSAY MARKET BY CELL DIFFERENTIATION ASSAYS 2019-2027 ($ MILLION)

FIGURE  7     GLOBAL STEM CELL ASSAY MARKET BY CELL FUNCTION ASSAYS 2019-2027 ($ MILLION)

FIGURE  8     GLOBAL STEM CELL ASSAY MARKET BY CELL APOPTOSIS ASSAYS 2019-2027 ($ MILLION)

FIGURE  9     GLOBAL STEM CELL ASSAY MARKET SHARE BY PRODUCT 2018 & 2027 (%)

FIGURE  10  GLOBAL STEM CELL ASSAY MARKET BY INSTRUMENTS 2019-2027 ($ MILLION)

FIGURE  11  GLOBAL STEM CELL ASSAY MARKET BY DETECTION KIT 2019-2027 ($ MILLION)

FIGURE  12  GLOBAL STEM CELL ASSAY MARKET SHARE BY TYPE OF ASSAY 2018 & 2027 (%)

FIGURE  13  GLOBAL STEM CELL ASSAY MARKET BY ADULT STEM CELL KIT 2019-2027 ($ MILLION)

FIGURE  14  GLOBAL ADULT STEM CELL KIT MARKET BY MESENCHYMAL STEM CELL KIT 2019-2027 ($ MILLION)

FIGURE  15  GLOBAL ADULT STEM CELL KIT MARKET BY INDUCED PLURIPOTENT STEM CELL KIT 2019-2027 ($ MILLION)

FIGURE  16  GLOBAL ADULT STEM CELL KIT MARKET BY HEMATOPOIETIC STEM CELL KIT 2019-2027 ($ MILLION)

FIGURE  17  GLOBAL ADULT STEM CELL KIT MARKET BY NEURONAL STEM CELL KIT 2019-2027 ($ MILLION)

FIGURE  18  GLOBAL ADULT STEM CELL KIT MARKET BY UMBILICAL CORD STEM CELL KIT 2019-2027 ($ MILLION)

FIGURE  19  GLOBAL STEM CELL ASSAY MARKET BY HUMAN EMBRYONIC STEM CELL KIT 2019-2027 ($ MILLION)

FIGURE  20  GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY REGENERATIVE MEDICINE  2019-2027 ($ MILLION)

FIGURE  21  GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY STEM CELL BIOLOGY RESEARCH  2019-2027 ($ MILLION)

FIGURE  22  GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY TISSUE ENGINEERING  2019-2027 ($ MILLION)

FIGURE  23  GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY TOXICOLOGY TESTING  2019-2027 ($ MILLION)

FIGURE  24  GLOBAL STEM CELL ASSAY MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE  25  GLOBAL STEM CELL ASSAY MARKET BY REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET 2019-2027 ($ MILLION)

FIGURE  26  GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY ORTHOPEDIC & MUSCULOSKELETAL SPINE  2019-2027 ($ MILLION)

FIGURE  27  GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY DERMATOLOGY  2019-2027 ($ MILLION)

FIGURE  28  GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY CARDIOVASCULAR  2019-2027 ($ MILLION)

FIGURE  29  GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY CENTRAL NERVOUS SYSTEM  2019-2027 ($ MILLION)

FIGURE  30  GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY ONCOLOGY  2019-2027 ($ MILLION)

FIGURE  31  GLOBAL STEM CELL ASSAY MARKET BY DRUG DISCOVERY & DEVELOPMENT MARKET 2019-2027 ($ MILLION)

FIGURE  32  GLOBAL STEM CELL ASSAY MARKET BY CLINICAL RESEARCH 2019-2027 ($ MILLION)

FIGURE  33  GLOBAL STEM CELL ASSAY MARKET SHARE BY END-USER 2018 & 2027 (%)

FIGURE  34  GLOBAL STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES MARKET 2019-2027 ($ MILLION)

FIGURE  35  GLOBAL STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH MARKET 2019-2027 ($ MILLION)

FIGURE  36  PORTER’S FIVE FORCE MODEL

FIGURE  37  GLOBAL STEM CELL ASSAY MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE  38  THE UNITED STATES STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  39  CANADA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  40  THE UNITED KINGDOM STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  41  GERMANY STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  42  FRANCE STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  43  ITALY STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  44  SPAIN STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  45  REST OF EUROPE STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  46  INDIA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  47  CHINA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  48  JAPAN STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  49  SOUTH KOREA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  50  AUSTRALIA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  51  REST OF ASIA-PACIFIC STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  52  LATIN AMERICA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  53  MIDDLE EAST AND AFRICA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)

FIGURE  54  STEM CELL ASSAY MARKET SHARE ANALYSIS OF KEY PLAYERS 2018 (%)

($ MILLION)

Segmentation

  1. MARKET BY TYPE OF ASSAY
    • CELL VIABILITY & TOXICITY ASSAYS
    • ISOLATION/PURIFICATION ASSAYS
    • CELL IDENTIFICATION ASSAYS
    • CELL DIFFERENTIATION ASSAYS
    • CELL FUNCTION ASSAYS
    • CELL APOPTOSIS ASSAYS
  2. MARKET BY PRODUCT
    • INSTRUMENTS
    • DETECTION KIT
  3. MARKET BY KITS
    • ADULT STEM CELL KIT
      • MESENCHYMAL STEM CELL KIT
      • INDUCED PLURIPOTENT STEM CELL KIT
      • HEMATOPOIETIC STEM CELL KIT
      • NEURONAL STEM CELL KIT
      • UMBILICAL CORD STEM CELL KIT
    • HUMAN EMBRYONIC STEM CELL KIT
      • REGENERATIVE MEDICINE
      • STEM CELL BIOLOGY RESEARCH
      • TISSUE ENGINEERING
      • TOXICOLOGY TESTING
  1. MARKET BY APPLICATION
    • REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET
      • ORTHOPEDIC & MUSCULOSKELETAL SPINE
      • DERMATOLOGY
      • CARDIOVASCULAR
      • CENTRAL NERVOUS SYSTEM
      • ONCOLOGY
    • DRUG DISCOVERY & DEVELOPMENT MARKET
    • CLINICAL RESEARCH
  2. MARKET BY END-USER
    • RESEARCH INSTITUTES
    • INDUSTRY RESEARCH
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA-PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

Request Free Sample

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Choose License Type

    Get In Touch

    Inquire Before Buying

    Customization

    Inkwood Research delivers customized reports as per the client's requirement to provide them with an edge in the competitive market

    Request Customization

    RELATED REPORTS